Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Bradwejn J

Collect these papers and discover other ones on Labmeeting. Learn more.

A multifaith spiritually based intervention for generalized anxiety disorder: a pilot randomized trial.

+ cite this

+ View Abstract

Koszycki D, Raab K, Aldosary F, and Bradwejn J

Journal of clinical psychology 66(4):430-41, 2010 Apr - Who cited this? | PubMed ID: 20143382 | Fulltext

Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial.

+ cite this

+ View Abstract

Bissada H, Tasca GA, Barber AM, and Bradwejn J

The American journal of psychiatry 165(10):1281-8, 2008 Oct - Who cited this? | PubMed ID: 18558642 | Fulltext

Randomized trial of a meditation-based stress reduction program and cognitive behavior therapy in generalized social anxiety disorder.

+ cite this

+ View Abstract

Koszycki D, Benger M, Shlik J, and Bradwejn J

Behaviour research and therapy 45(10):2518-26, 2007 Oct - Who cited this? | PubMed ID: 17572382 | Fulltext

Fetal gender and postpartum depression in a cohort of Chinese women.

+ cite this

+ View Abstract

Xie RH, He G, Liu A, Bradwejn J, Walker M, and Wen SW

Social science & medicine (1982) 65(4):680-4, 2007 Aug - Who cited this? | PubMed ID: 17507127 | Fulltext

Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder.

+ cite this

+ View Abstract

Rothe C, Koszycki D, Bradwejn J, King N, Deluca V, Tharmalingam S, Macciardi F, Deckert J, and Kennedy JL

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 31(10):2237, 2006 Oct - Who cited this? | PubMed ID: 16525418 | Fulltext

Lack of association between the corticotrophin-releasing hormone receptor 2 gene and panic disorder.

+ cite this

+ View Abstract

Tharmalingam S, King N, De Luca V, Rothe C, Koszycki D, Bradwejn J, Macciardi F, and Kennedy JL

Psychiatric genetics 16(3):93-7, 2006 Jun - Who cited this? | PubMed ID: 16691126 | Fulltext

Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study.

+ cite this

+ View Abstract

Bradwejn J, Ahokas A, Stein DJ, Salinas E, Emilien G, and Whitaker T

The British journal of psychiatry : the journal of mental science 187:352-9, 2005 Oct - Who cited this? | PubMed ID: 16199795 | Fulltext

A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.

+ cite this

+ View Abstract

Liebowitz MR, Mangano RM, Bradwejn J, Asnis G, and SAD Study Group

The Journal of clinical psychiatry 66(2):238-47, 2005 Feb - Who cited this? | PubMed ID: 15705011 | Fulltext

Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.

+ cite this

+ View Abstract

Koszycki D, Torres S, Swain JE, and Bradwejn J

Psychosomatic medicine 67(4):590-5, 2005 - Who cited this? | PubMed ID: 16046372 | Fulltext

Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and Germany.

+ cite this

+ View Abstract

Rothe C, Koszycki D, Bradwejn J, King N, De Luca V, Shaikh S, Franke P, Garritsen H, Fritze J, Deckert J, and Kennedy JL

Neuroscience letters 363(3):276-9, 2004 Jun 17 - Who cited this? | PubMed ID: 15182959 | Fulltext

Sensitivity to cholecystokinin-tetrapeptide in major depression.

+ cite this

+ View Abstract

Koszycki D, Copen J, and Bradwejn J

Journal of affective disorders 80(2-3):285-90, 2004 Jun - Who cited this? | PubMed ID: 15207943 | Fulltext

Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder.

+ cite this

+ View Abstract

Katzman MA, Koszycki D, and Bradwejn J

Depression and anxiety 20(2):51-8, 2004 - Who cited this? | PubMed ID: 15390214 | Fulltext

Assessing patient beliefs in a clinical trial of Hypericum perforatum in major depression.

+ cite this

+ View Abstract

Bann CM, Parker CB, Bradwejn J, Davidson JR, Vitiello B, and Gadde KM

Depression and anxiety 20(3):114-22, 2004 - Who cited this? | PubMed ID: 15549690 | Fulltext

Acute effects of cholecystokinin tetrapeptide on brain stem auditory evoked potentials in healthy volunteers.

+ cite this

+ View Abstract

Gunnarsson T, Mahoney C, Shlik J, Bradwejn J, and Knott V

Pharmacopsychiatry 36(5):181-6, 2003 Sep - Who cited this? | PubMed ID: 14571352 | Fulltext

Effects of acute cholecystokinin infusion on hemispheric EEG asymmetry and coherence in healthy volunteers.

+ cite this

+ View Abstract

Knott V, Mahoney C, Bradwejn J, Shlik J, and Gunnarsson T

Progress in neuro-psychopharmacology & biological psychiatry 27(1):179-84, 2003 Feb - Who cited this? | PubMed ID: 12551742 | Fulltext

Aging and panicogenic response to cholecystokinin tetrapeptide: an examination of the cholecystokinin system.

+ cite this

+ View Abstract

Flint A, Bradwejn J, Vaccarino F, Gutkowska J, Palmour R, and Koszycki D

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 27(4):663-71, 2002 Oct - Who cited this? | PubMed ID: 12377403 | Fulltext

Mental health reform and evolution of general psychiatry in Ontario.

+ cite this

+ View Abstract

Swenson JR and Bradwejn J

Canadian journal of psychiatry. Revue canadienne de psychiatrie 47(7):644-51, 2002 Sep - Who cited this? | PubMed ID: 12355676 | Fulltext

Acute cholecystokinin effects on event-related potentials in healthy volunteers.

+ cite this

+ View Abstract

Knott VJ, Mahoney C, Gunnarsson T, Bradwejn J, and Shlik J

Human psychopharmacology 17(6):285-91, 2002 Aug - Who cited this? | PubMed ID: 12404673 | Fulltext

The ventilatory response to cholecystokinin tetrapeptide in healthy volunteers.

+ cite this

+ View Abstract

Katzman MA, Duffin J, Shlik J, and Bradwejn J

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 26(6):824-31, 2002 Jun - Who cited this? | PubMed ID: 12007753 | Fulltext

Using financial incentives to promote shared mental health care.

+ cite this

Swenson RJ and Bradwejn J

Canadian journal of psychiatry. Revue canadienne de psychiatrie 47(2):194-5, 2002 Mar - Who cited this? | PubMed ID: 11926083 | Fulltext

The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4.

+ cite this

+ View Abstract

Le Mellédo JM, Arthur H, Dalton J, Woo C, Lipton N, Bellavance F, Koszycki D, Boulenger JP, and Bradwejn J

Journal of psychosomatic research 51(3):513-20, 2001 Sep - Who cited this? | PubMed ID: 11602221 | Fulltext

Arginine-vasopressin and oxytocin response to cholecystokinin-tetrapeptide.

+ cite this

+ View Abstract

Le Mellédo JM, Bradwejn J, Koszycki D, Bellavance F, and Bichet D

Peptides 22(8):1349-57, 2001 Aug - Who cited this? | PubMed ID: 11457531 | Fulltext

Anxiety sensitivity does not predict fearful responding to 35% carbon dioxide in patients with panic disorder.

+ cite this

+ View Abstract

Koszycki D and Bradwejn J

Psychiatry research 101(2):137-43, 2001 Mar 25 - Who cited this? | PubMed ID: 11286817 | Fulltext

Cholecystokinin and panic disorder: past and future clinical research strategies.

+ cite this

+ View Abstract

Bradwejn J and Koszycki D

Scandinavian journal of clinical and laboratory investigation. Supplementum 234:19-27, 2001 - Who cited this? | PubMed ID: 11713976 | Fulltext

A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects.

+ cite this

+ View Abstract

Bradwejn J, Zhou Y, Koszycki D, and Shlik J

Journal of clinical psychopharmacology 20(6):680-4, 2000 Dec - Who cited this? | PubMed ID: 11106141 | Fulltext

Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects.

+ cite this

+ View Abstract

Flint AJ, Koszycki D, Bradwejn J, and Vaccarino FJ

Psychoneuroendocrinology 25(6):633-47, 2000 Aug - Who cited this? | PubMed ID: 10840174 | Fulltext

International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors.

+ cite this

Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, and Roques BP

Pharmacological reviews 51(4):745-81, 1999 Dec - Who cited this? | PubMed ID: 10581329 | Fulltext

Effects of CCK-4 infusion on the acoustic eye-blink startle and psychophysiological measures in healthy volunteers.

+ cite this

+ View Abstract

Shlik J, Zhou Y, Koszycki D, Vaccarino FJ, and Bradwejn J

Journal of psychopharmacology (Oxford, England) 13(4):385-90, 1999 Dec - Who cited this? | PubMed ID: 10667615 | Fulltext

Investigation of cholecystokinin system genes in panic disorder.

+ cite this

+ View Abstract

Kennedy JL, Bradwejn J, Koszycki D, King N, Crowe R, Vincent J, and Fourie O

Molecular psychiatry 4(3):284-5, 1999 May - Who cited this? | PubMed ID: 10395221 | Fulltext

Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points.

+ cite this

+ View Abstract

Javanmard M, Shlik J, Kennedy SH, Vaccarino FJ, Houle S, and Bradwejn J

Biological psychiatry 45(7):872-82, 1999 Apr 1 - Who cited this? | PubMed ID: 10202575 | Fulltext

Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans.

+ cite this

+ View Abstract

Dépôt M, Caillé G, Mukherjee J, Katzman MA, Cadieux A, and Bradwejn J

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20(2):177-87, 1999 Feb - Who cited this? | PubMed ID: 9885797 | Fulltext

Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases.

+ cite this

+ View Abstract

Le Mellédo JM, Merani S, Koszycki D, Bellavance F, Palmour R, Gutkowska J, Steinberg S, Bichet DG, and Bradwejn J

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20(1):81-91, 1999 Jan - Who cited this? | PubMed ID: 9885787 | Fulltext

CCK4-induced panic in healthy subjects I: psychological and cardiovascular effects.

+ cite this

+ View Abstract

Jerabek I, Boulenger JP, Bradwejn J, Lavallée YJ, and Jolicoeur FB

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 9(1-2):149-55, 1999 Jan - Who cited this? | PubMed ID: 10082241 | Fulltext

CCK4-induced panic in healthy subjects II: neurochemical correlates.

+ cite this

+ View Abstract

Jerabek I, Boulenger JP, Bradwejn J, Drumheller A, Lavallée YJ, and Jolicoeur FB

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 9(1-2):157-64, 1999 Jan - Who cited this? | PubMed ID: 10082242 | Fulltext

Effect of oral ondansetron on total cholecystokinin plasma levels following CCK-4 panic challenge procedure in healthy men.

+ cite this

+ View Abstract

Dépôt M, Merani S, Bradwejn J, Mukherjee J, Caillé J, Gutkowska J, and Caillé G

Journal of psychiatry & neuroscience : JPN 23(5):298-304, 1998 Nov - Who cited this? | PubMed ID: 9846035 | Fulltext

The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms.

+ cite this

+ View Abstract

Le Mellédo JM, Bradwejn J, Koszycki D, Bichet DG, and Bellavance F

Biological psychiatry 44(5):364-6, 1998 Sep 1 - Who cited this? | PubMed ID: 9755359 | Fulltext

MMPI scales for diagnosing acute and chronic PTSD in civilians. Minnesota Multiphasic Personality Inventory.

+ cite this

+ View Abstract

Gaston L, Brunet A, Koszycki D, and Bradwejn J

Journal of traumatic stress 11(2):355-65, 1998 Apr - Who cited this? | PubMed ID: 9565920 | Fulltext

Effects of cholecystokinin tetrapeptide on respiratory function in healthy volunteers.

+ cite this

+ View Abstract

Bradwejn J, LeGrand JM, Koszycki D, Bates JH, and Bourin M

The American journal of psychiatry 155(2):280-2, 1998 Feb - Who cited this? | PubMed ID: 9464212 | Fulltext

Effect of aging on cholecystokinin-induced panic.

+ cite this

+ View Abstract

Flint AJ, Koszycki D, Vaccarino FJ, Cadieux A, Boulenger JP, and Bradwejn J

The American journal of psychiatry 155(2):283-5, 1998 Feb - Who cited this? | PubMed ID: 9464213 | Fulltext

Neurobiology of panic disorder.

+ cite this

+ View Abstract

Bourin M, Baker GB, and Bradwejn J

Journal of psychosomatic research 44(1):163-80, 1998 Jan - Who cited this? | PubMed ID: 9483472 | Fulltext

Decrease in short-term memory function induced by CCK-4 in healthy volunteers.

+ cite this

+ View Abstract

Shlik J, Koszycki D, and Bradwejn J

Peptides 19(6):969-75, 1998 - Who cited this? | PubMed ID: 9700743 | Fulltext

Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.

+ cite this

+ View Abstract

Koszycki D, Zacharko RM, Le Mellédo JM, and Bradwejn J

Depression and anxiety 8(1):1-7, 1998 - Who cited this? | PubMed ID: 9750972 | Fulltext

Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.

+ cite this

+ View Abstract

Shlik J, Aluoja A, Vasar V, Vasar E, Podar T, and Bradwejn J

Journal of psychiatry & neuroscience : JPN 22(5):332-40, 1997 Nov - Who cited this? | PubMed ID: 9401314 | Fulltext

The effect of cholecystokinin tetrapeptide on respiratory resistance in healthy volunteers.

+ cite this

+ View Abstract

Shlik J, Vasar V, Aluoja A, Kingisepp PH, Jagomägi K, Vasar E, Rägo L, and Bradwejn J

Biological psychiatry 42(3):206-12, 1997 Aug 1 - Who cited this? | PubMed ID: 9232213 | Fulltext

Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder.

+ cite this

+ View Abstract

Brawman-Mintzer O, Lydiard RB, Bradwejn J, Villarreal G, Knapp R, Emmanuel N, Ware MR, He Q, and Ballenger JC

The American journal of psychiatry 154(5):700-2, 1997 May - Who cited this? | PubMed ID: 9137133 | Fulltext

Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat.

+ cite this

+ View Abstract

Frankland PW, Josselyn SA, Bradwejn J, Vaccarino FJ, and Yeomans JS

The Journal of neuroscience : the official journal of the Society for Neuroscience 17(5):1838-47, 1997 Mar 1 - Who cited this? | PubMed ID: 9030642 | Fulltext

Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers.

+ cite this

+ View Abstract

Aluoja A, Shlik J, Vasar V, Kingisepp PH, Jagomägi K, Vasar E, and Bradwejn J

Psychiatry research 66(1):59-67, 1997 Jan 15 - Who cited this? | PubMed ID: 9061804 | Fulltext

Development of a sensitive and specific assay system for cholecystokinin tetrapeptide.

+ cite this

+ View Abstract

Merani S, Palmour RM, Bradwejn J, Berezowska I, Vaccarino FJ, and Gutkowska J

Peptides 18(6):869-75, 1997 - Who cited this? | PubMed ID: 9285937 | Fulltext

Effect of acute tryptophan depletion on behavioral, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers.

+ cite this

+ View Abstract

Koszycki D, Zacharko RM, Le Melledo JM, Young SN, and Bradwejn J

Biological psychiatry 40(7):648-55, 1996 Oct 1 - Who cited this? | PubMed ID: 8886299 | Fulltext

MMPI profiles of acute and chronic PTSD in a civilian sample.

+ cite this

+ View Abstract

Gaston L, Brunet A, Koszycki D, and Bradwejn J

Journal of traumatic stress 9(4):817-32, 1996 Oct - Who cited this? | PubMed ID: 8902748 | Fulltext

Search Google Scholar for Bradwejn J

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.